In lymphoblastic leukemia, Hh pathway components are upregulated in precursor B-ALL, and SMO inhibitor has been reported to reduce self-renewal of ALL cells in vitro and in vivo [173,184]. The gene discussed is SMO; the disease is acute lymphoblastic leukemia.